Hyundai Pharm to conduct clinical trial of acebrophylline in China

Hyundai Pharmaceutical has recently announced the commencement of clinical trial for Surfolase (acebrophylline) capsules in China during the latter half of this year.

This clinical trial, which was accepted by the Chinese health authorities on March 5, will be undertaken from local university hospitals in collaboration with a leading clinical research organization in China.

Developed by P...